Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Datsenko

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Voprosy Onkologii|May 29, 2015
[Hodgkin's lymphoma and radiotherapy]P V Datsenko, G A Panshin
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|August 8, 2020
[Short-term survival prediction scale in patients with metastatic brain disease caused by lung and breast cancer]P V Datsenko, V A Gerasimov, A A Belikova
Voprosy Onkologii|August 15, 2012
[The role of functional status and recursive partition analysis (RPA) classes for the choice of fractionation regimen in patients with high-grade gliomas]T R Izmaĭlov, G A Pan'shin, P V Datsenko
Voprosy Onkologii|December 9, 2010
[Risk factors and long-term results of radiotherapy in grade-3 and -4 brain neoplasms]T R Ismaĭlov, G A Pan'shin, P V Datsenko
Voprosy Onkologii|August 15, 2012
[The role of age and tumor grade in the choice of fractionation regimen in patients with high-grade gliomas]T R Izmaĭlov, G A Pan'shin, P V Datsenko
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|February 3, 2018
[Hypofractionated radiotherapy for glioblastoma: changing the radiation treatment paradigm]V A Gerasimov, V V Boldyreva, P V Datsenko
Voprosy Onkologii|December 16, 2006
[Prognostic models for Hodgkin's disease]G A Panyshin, P V Datsenko, V M Sotnikov, et al.
Voprosy Onkologii|April 24, 2013
[The role of RPA classification in the treatment of high-grade gliomas]T R Izmaĭlov, G A Pan'shin, P V Datsenko, et al.
Voprosy Onkologii|November 23, 2013
[Evaluation the effectiveness of radiation therapy high-grade gliomas based on the model of TDF (time-dose fractionation)]T R Izmaĭlov, G A Pan'shin, S M Misliukov, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|February 11, 2026
[Overall survival prediction scale for patients with grade 4 brain astrocytoma]P V Datsenko, A S Chuguev, V A Gerasimov, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Voprosy Onkologii|May 29, 2015
[Hodgkin's lymphoma and radiotherapy]P V Datsenko, G A Panshin
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|August 8, 2020
[Short-term survival prediction scale in patients with metastatic brain disease caused by lung and breast cancer]P V Datsenko, V A Gerasimov, A A Belikova
Voprosy Onkologii|August 15, 2012
[The role of functional status and recursive partition analysis (RPA) classes for the choice of fractionation regimen in patients with high-grade gliomas]T R Izmaĭlov, G A Pan'shin, P V Datsenko
Voprosy Onkologii|December 9, 2010
[Risk factors and long-term results of radiotherapy in grade-3 and -4 brain neoplasms]T R Ismaĭlov, G A Pan'shin, P V Datsenko
Voprosy Onkologii|August 15, 2012
[The role of age and tumor grade in the choice of fractionation regimen in patients with high-grade gliomas]T R Izmaĭlov, G A Pan'shin, P V Datsenko
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|February 3, 2018
[Hypofractionated radiotherapy for glioblastoma: changing the radiation treatment paradigm]V A Gerasimov, V V Boldyreva, P V Datsenko
Voprosy Onkologii|December 16, 2006
[Prognostic models for Hodgkin's disease]G A Panyshin, P V Datsenko, V M Sotnikov, et al.
Voprosy Onkologii|April 24, 2013
[The role of RPA classification in the treatment of high-grade gliomas]T R Izmaĭlov, G A Pan'shin, P V Datsenko, et al.
Voprosy Onkologii|November 23, 2013
[Evaluation the effectiveness of radiation therapy high-grade gliomas based on the model of TDF (time-dose fractionation)]T R Izmaĭlov, G A Pan'shin, S M Misliukov, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|February 11, 2026
[Overall survival prediction scale for patients with grade 4 brain astrocytoma]P V Datsenko, A S Chuguev, V A Gerasimov, et al.
Pageof 3